Conclusions: Sustained-release isosorbide mononitrate, which is safe and well tolerated, can effectively control BP, decrease the category and quantity of hypotensive drugs, improve left ventricular hypertrophy and reduce the incidence of acute left heart failure in MHD patients.
PMID: 21240870 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)